Adverse effects using combined rate-slowing antihypertensive agents.
作者信息
Handler Joel
机构信息
Kaiser Permanente, Anaheim, CA 92807, USA.
出版信息
J Clin Hypertens (Greenwich). 2011 Jul;13(7):529-32. doi: 10.1111/j.1751-7176.2011.00486.x. Epub 2011 Jun 20.
Abstract
摘要
相似文献
1
Adverse effects using combined rate-slowing antihypertensive agents.
J Clin Hypertens (Greenwich). 2011 Jul;13(7):529-32. doi: 10.1111/j.1751-7176.2011.00486.x. Epub 2011 Jun 20.
2
Polypharmacy and combination therapy in the management of hypertension in elderly patients with co-morbid diabetes mellitus.
Drugs Aging. 2010 Nov 1;27(11):871-83. doi: 10.2165/11538650-000000000-00000.
3
Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
Drugs R D. 2011;11(2):171-90. doi: 10.2165/11592450-000000000-00000.
4
Losartan-ramipril combination treatment.
J Assoc Physicians India. 2004 May;52:429.
5
[Treatment for the elderly hypertensive patient with renal insufficiency].
Nihon Rinsho. 2005 Jun;63(6):1047-51.
6
Intraventricular aberrancy, pseudo-supernormality and intrahisian conduction "gap" in premature junctional beats.
Int J Cardiol. 2015 Dec 15;201:490-2. doi: 10.1016/j.ijcard.2014.09.093. Epub 2014 Sep 28.
7
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus.
Diabetes Obes Metab. 2012 Apr;14(4):341-7. doi: 10.1111/j.1463-1326.2011.01535.x. Epub 2011 Dec 27.
8
Reevaluating the use of antihypertensive medications, a first step toward reducing polypharmacy in very old patients.
J Clin Hypertens (Greenwich). 2010 Aug;12(8):621-4. doi: 10.1111/j.1751-7176.2010.00304.x.
9
Cisplatin-induced bradycardia and the importance of the QT interval.
J Oncol Pharm Pract. 2015 Apr;21(2):157-60. doi: 10.1177/1078155214522314. Epub 2014 Feb 20.
10
[Irbesartan in clinical practice].
Kardiologiia. 2012;52(11):66-74.
引用本文的文献
1
Austrian consensus statement on the diagnosis and management of hypertrophic cardiomyopathy.
Wien Klin Wochenschr. 2024 Oct;136(Suppl 15):571-597. doi: 10.1007/s00508-024-02442-1. Epub 2024 Oct 1.
2
In situ diagnosis and simultaneous treatment of cardiac diseases using a single-device platform.
Sci Adv. 2022 Sep 16;8(37):eabq0897. doi: 10.1126/sciadv.abq0897. Epub 2022 Sep 14.
3
Thyroid Hormone Resistance in Identical Twin Sisters with Atrial Fibrillation: Case Report and Review of the Literature.
J Endocrinol Diabetes. 2018;5(4). doi: 10.15226/2374-6890/5/4/01111. Epub 2018 Jul 23.
本文引用的文献
1
Prognosis and natural history of drug-related bradycardia.
Korean Circ J. 2009 Sep;39(9):367-71. doi: 10.4070/kcj.2009.39.9.367. Epub 2009 Sep 30.
2
Managing hypertension in the elderly in light of the changes during aging.
Blood Press. 2008;17(4):186-94. doi: 10.1080/08037050802305578.
3
Cardiovascular drug therapy in the elderly.
Cardiol Rev. 2007 Jul-Aug;15(4):195-215. doi: 10.1097/CRD.0b013e3180301b69.
4
Treatment of poisoning caused by beta-adrenergic and calcium-channel blockers.
Am J Health Syst Pharm. 2006 Oct 1;63(19):1828-35. doi: 10.2146/ajhp060041.
5
Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.
Lancet. 2005;366(9496):1545-53. doi: 10.1016/S0140-6736(05)67573-3.
6
Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.
J La State Med Soc. 2004 Nov-Dec;156(6):327-31.
7
Atenolol in hypertension: is it a wise choice?
Lancet. 2004;364(9446):1684-9. doi: 10.1016/S0140-6736(04)17355-8.
8
Bradycardia and medications: identify the dangerous pace.
Nurs Manage. 2003 Jun;34(6):56A-56F. doi: 10.1097/00006247-200306000-00021.
9
Beta-adrenoceptor-blocking drugs in the elderly.
J Cardiovasc Pharmacol. 1990;16 Suppl 5:S25-8.
10
Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.
Jpn Circ J. 2000 Nov;64(11):893-6. doi: 10.1253/jcj.64.893.
Zotero 插件